Hal Trust

Q1: no disruption to GrandVision deal

20/05/20 -"As expected, HAL’s NAV was hit by the market turmoil experienced since the end of February. Although the share prices of HAL’s listed assets drove this decrease, the health crisis impact ..."

PDF page sample
Pages
52
Language
English
Published on
20/05/20
Download
You may also be interested by these reports :
13/01/26
We have materially lowered our target price while maintaining a constructive long-term outlook. This downward revision mainly reflects the recent ...
07/01/26
Q1 revenue was aligned with consensus, with uneven geographic performance: Continental Europe faced macro headwinds and delivered modest growth, ...
06/01/26
Benefitting from elevated inflation and interest rates, which support higher issuance volumes and float income, Edenred (BUY ; France) reached an ...
05/01/26
With no near-term visibility on Edenred’s joint appeals against the recent regulatory changes in Italy and Brazil, we have finally revised our ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO